Wall Street’s Top Analysts Upgrades, Downgrades & Initiations

Wall Street’s Top Analysts Upgrades, Downgrades & Initiations


Daily HeffX-LTN reviews Wall Street analysts research reports to find new investing and trading ideas for our readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of Wall Street’s Top analysts outlook for Key issues for Friday, as follows:

ABIOMED Inc. (NASDAQ:ABMD) analysts reiterated as Buy and the price target was raised to 220 from 208 at Jefferies. The stock has a 52-wk trading range of 103.53 – 200.28.

Bed Bath & Beyond Inc. (NASDAQ:BBBY) Jefferies reiterated it at Hold with a 25 price target. Wedbush Securities maintained its Neutral rating and lowered its price target to 23. Credit Suisse reiterated its Neutral rating, noting that margins are falling and that its stabilization path is unclear. Merrill Lynch reiterated its Underperform rating and 19 price objective.

BlackBerry Ltd. (NYSE:BB) was up on earnings, Merrill Lynch called it a low-quality earnings beat and maintained its Underperform rating and 8 price objective. BMO Capital Markets maintained its Market Perform rating but raised its target to 12 from 10.

ConocoPhillips (NYSE:COP) was downgraded to Sector Perform with a 58 price target at Scotia Howard Weil. The stock was removed from its Focus List.

Have a Happy Christmas Holiday Weekend.


The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

You must be logged in to post comments :